Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity
暂无分享,去创建一个
S. Salek | A. Fielding | G. Collins | J. Kell | E. Olíva | M. Karakantza | S. McConnell | S. Al-Ismail | T. Ionova | P. Goswami | R. Else | C. Langton | Daniel M. Jennings